News
$250,000 grant will study effects of cancer treatment on fertility
Institute's Dr. Ilana Chefetz will lead innovative study to help young women
U Researcher Leads National Study to Optimize Response Assessment with Prostate Cancer Treatments
Author: Angel Mendez, UMN Medical School Communications Manager
When Arpit Rao, MBBS, began his oncology rotations during residency, it wasn't the practice that inspired his career in prostate cancer research and treatment—it was the…
Talking cancer prevention with U of M
February is National Cancer Prevention Month. In Minnesota, there are an estimated 142,369 new cancer cases every year.
Professor Timothy Church with the University of Minnesota answers questions on lifestyle changes people can make to…
Understanding Cancer: Prevention
While February 4th was World Cancer Day, the entire month of February is honored as National Cancer Prevention Month. Cancer is an invasive and devastating disease that can affect anyone, regardless of age, gender, or race. Fortunately,…
Masonic Cancer Center Member Branden Moriarity Receives U24 Grant with Recombinetics, Inc
Funding allows further testing of genome editing technologies
University of Minnesota researchers e
Masonic Cancer Center named to the National Institute of Environmental Health Sciences Study
December 13, 2019
The Masonic Cancer Center is now part of the Human Health Exposure Analysis Resource (HHEAR) program, a continuation of the groundbreaking Children's Health Exposure Analysis Resource (CHEAR).
U of M Opens Three First-in-human Trials in One Month
A new cancer treatment therapy is being tested for the first time in patients at the M Health Fairview University of Minnesota Medical Center.
U of M opens new first-in-human clinical trial for the treatment of advanced solid tumors
The University of Minnesota has become the third location in the United States to open a promising cell-based cancer immunotherapy clinical trial for the treatment of advanced solid tumors. The multicentered trial is investigating the…
University of Minnesota discovery is now a first-in-human clinical trial for leukemia
Designer molecule will activate the patient's own immune cells to attack cancer
The discovery of tri-specific natural killer engagers (TriKE™), a combination protein that bridges an immune cell and a tumor cell to drive tumor cell killing…
Masonic Cancer Center, University of Minnesota is hosting the first-ever Cancer Center Community Impact Forum (CCCIF)
The Masonic Cancer Center, University of Minnesota is hosting the first-ever Cancer Center Community Impact Forum (CCCIF)
Community engagement professionals, researchers, and clinicians from cancer centers nationwide, as well as the…